Sandbox Hires Nick Rambke and Tracy Draksler Brown as SVPs of Client Services
Independent, full-service agency Sandbox announced the hiring of Nick Rambke and Tracy Draksler Brown as SVPs of client services.
REALITYRx Communication Hires New SVP, Management Supervisor
REALITYRx Communication announced that Scott Greisler joined the agency in the role of SVP, Management Supervisor.
Benchworks Hires Media Director
Agency to step up strategic media planning and buying Chestertown, MD, October 24, 2018 – Benchworks is pleased to announce that Karima Sharif has joined the company as Senior Vice President, Media Director. She will lead all strategic media planning and nonpersonal promotion (NPP) services for clients. Karima joins Benchworks with a wide depth and […]
Pfizer Announces 2 Percent Jobs Cuts Worldwide
Citing structural simplification, Pfizer announced plans to cut the company’s global staffing by about 2 percent, primarily through voluntary layoffs and early retirement through the end of 2018 and early in 2019.
Novo Nordisk hires AstraZeneca executive
Novo Nordisk is in advanced talks to acquire assets to bolster the company’s struggling biopharma business after the drugmaker announced the hiring of an AstraZeneca executive to head the unit.
FCB Chicago hires Cherie Davies as SVP, Group Creative Director
Cherie Davies joined FCB Chicago as SVP, Group Creative Director.
Fingerpaint Opens New Jersey Office
Fingerpaint opened an office in Morristown, N.J., heading by Mark Willmann. The healthcare agency’s first office in New Jersey joins other locations in New York, Pennsylvania, Arizona, and Ohio.
Pfizer Announces Ian Read’s Replacement and Succession Plan
Pfizer announced the company’s succession plan for when Ian Read steps down as chief executive officer on January 1, 2019.
McCann Health Appoints Sam Taylor To Lead Global GSK Business
McCann Health announced the appointment of Sam Taylor as Global Business Leader for its GlaxoSmithKline (GSK) global business.
Astellas Pushes Outside of Oncology, Releases Positive Results in Anemia Trials
Tokyo-based Astellas Pharma announced that the company’s roxadustat met the primary endpoints in the Phase III ALPS clinical trial in chronic kidney disease patients with anemia not on dialysis.
Ad Right Top
MedAdNews
Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.
October 2018 Focus: Top 50 Pharma, Company of the Year and more!